Status:
COMPLETED
Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions:
Fibrosis
Chronic Liver Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
Hepatitis C virus (HCV) infection causes different disease spectrum ranging from minimal progressive liver disease to cirrhosis or hepatocellular carcinoma. Evidence indicates that host genetic factor...
Detailed Description
Determination of the following fibrosis-relating gene polymorphisms in HCV-related chronic liver disease and HCC will be performed: TNF-α , TNF-β, Factor V Leiden, TGF-β1, PDGF-B gene, Angiotensinogen...
Eligibility Criteria
Inclusion
- Patients with anti-HCV positive
Exclusion
- Anti-HCV-negative patients
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00629603
Start Date
January 1 2007
End Date
September 1 2009
Last Update
April 18 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University Chung-Ho Hospital
Kaohsiung City, Kaohsiung, Taiwan, 807
2
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Kaohsiung, Taiwan, 807